Debut Plus

₹527.25

▼ -3.02 -0.57%

17 Jul 2026

NSE Listed · Healthcare

Thyrocare Tech Ltd. (THYROCARE)

Volume: 34,621Avg Vol 1W: 1,56,701Avg Vol 1M: 1,82,85552W Range:₹342.55₹578.25
NSE BSE www.thyrocare.com
Key Ratios
Checked just now
Market Cap₹8,392 Cr
Current Price₹527.25
Previous Close₹530.27
High / Low (52w)₹578.25 / ₹342.55
Volume34,621
Avg Vol (1W)1,56,701
Avg Vol (1M)1,82,855
Stock P/E176.34
Book Value₹32.21
Dividend Yield2.65%
ROE27.85%
ROA21.79%
Revenue (TTM)₹829 Cr
Revenue Growth20.61%
Profit Margin19.67%
Total Debt₹0 Cr
Shares Outstanding16 Cr
Face Value₹10
EPS (TTM)₹10.1
P/B16.37
Debt / Equity0.07
50 DMA₹535.4
200 DMA₹450.93
Day change-0.57%
Price Chart
₹527.25▲ 7.84% · 1Y
₹558₹3501.1Cr
2025-11-24
2026-07-16

20-day avg volume: 1.9L shares

Pros
  • Healthy return on equity of 27.9%.
  • Pays a dividend yield of 2.6%.
  • Company is almost debt-free.
  • Revenue grew 20% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 176.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹157 Cr₹177 Cr₹166 Cr₹187 Cr₹193 Cr₹217 Cr₹196 Cr₹224 Cr
EBITDA₹35 Cr₹38 Cr₹29 Cr₹49 Cr₹51 Cr₹63 Cr₹41 Cr₹65 Cr
Net Profit₹24 Cr₹27 Cr₹19 Cr₹22 Cr₹39 Cr₹48 Cr₹29 Cr₹47 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹413 Cr₹441 Cr₹507 Cr₹618 Cr₹535 Cr₹581 Cr₹702 Cr₹846 Cr
EBITDA₹138 Cr₹148 Cr₹153 Cr₹230 Cr₹90 Cr₹100 Cr₹150 Cr₹220 Cr
Net Profit₹85 Cr₹88 Cr₹113 Cr₹176 Cr₹64 Cr₹71 Cr₹92 Cr₹163 Cr
EPS15.9116.7121.3733.2512.1413.417.0810.24
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹475 Cr₹471 Cr₹546 Cr₹608 Cr₹633 Cr₹644 Cr₹693 Cr₹747 Cr
Total Liabilities₹40 Cr₹104 Cr₹119 Cr₹81 Cr₹98 Cr₹116 Cr₹146 Cr₹161 Cr
Equity₹435 Cr₹367 Cr₹427 Cr₹527 Cr₹535 Cr₹528 Cr₹547 Cr₹586 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹161 Cr₹212 Cr₹158 Cr₹170 Cr₹158 Cr₹197 Cr₹233 Cr₹273 Cr
Investing₹-12 Cr₹1 Cr₹-49 Cr₹-24 Cr₹-39 Cr₹-91 Cr₹-53 Cr₹-23 Cr
Financing₹-94 Cr₹-165 Cr₹-62 Cr₹-89 Cr₹-86 Cr₹-85 Cr₹-130 Cr₹-170 Cr
Free Cash Flow₹161 Cr₹212 Cr₹158 Cr₹170 Cr₹158 Cr₹197 Cr₹233 Cr₹273 Cr
Shareholding
Promoter 60.92% Institutions 26.36% Public 12.72%
About Thyrocare Tech Ltd.

Healthcare · Healthcare

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

www.thyrocare.com ↗
Efficiency & Working Capital
ROCE33.9%
Interest Coverage54.8
Dividend Payout—
Debtor Days33 d
Inventory Days21 d
Payable Days29 d
Cash Conversion Cycle25 d
Working Capital Days54 d
Shareholding Details

As of 2026-06-30

Promoter60.9%
FII5.4%
DII20.9%
Institutions26.4%
Public12.7%
Promoter Pledge100%
No. of Shareholders73,064
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters71.1%71.1%71.1%71.1%71.1%71.1%71.1%71.1%71.1%60.9%60.9%60.9%
FIIs3.5%3.3%2.9%2.5%1.9%2.8%2.4%3.2%4.8%5%5.4%5.4%
DIIs13.3%13.6%14.9%14.9%14.8%14.7%15%14.5%13.5%20.5%21%20.9%
Public12.1%12%11.1%11.5%12.2%11.5%11.6%11.2%10.6%13.6%12.7%12.7%
Promoter Pledge100%100%100%100%100%100%100%100%85.8%100%100%100%
No. of Shareholders72,00068,84464,82361,63659,37756,66657,40354,56654,14277,61973,37773,064
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Docon Technologies Private LimitedShareholding of Promoter and Promoter Group60.9%9.70 Cr
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap FundPublic Shareholding6%95,34,712
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) FundPublic Shareholding5.6%88,57,893
Hsbc Mutual Fund - Hsbc Midcap FundPublic Shareholding3.8%61,10,670
Aditya Birla Sun Life Trustee Private Limited A/c - Aditya Birla Sun Life Elss Tax Saver FundPublic Shareholding3.2%50,07,086
Api Holdings LimitedShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Docon Technologies Private Limited9.70 Cr100%2026-06-30
Api Holdings Limited00%2026-06-30
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund00%2026-06-30
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) Fund00%2026-06-30
Hsbc Mutual Fund - Hsbc Midcap Fund00%2026-06-30
Aditya Birla Sun Life Trustee Private Limited A/c - Aditya Birla Sun Life Elss Tax Saver Fund00%2026-06-30
Docon Technologies Private Limited9.70 Cr100%2026-03-31
Api Holdings Limited00%2026-03-31
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund00%2026-03-31
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) Fund00%2026-03-31
Hsbc Mutual Fund - Hsbc Midcap Fund00%2026-03-31
Aditya Birla Sun Life Trustee Private Limited A/c - Aditya Birla Sun Life Elss Tax Saver Fund00%2026-03-31
Board of Directors
NameDesignationYear
Rahul Franklin GuhaChairman / Executive Director / MD / CEO2026
Alok Kumar JagnaniNon Independent Non Executive Director / CFO2026
Uday Patel KadamNon-Exec & Non-Independent Dir2026
Gaurav VermaNon-Exec & Non-Independent Dir2026
Indumati GopinathanIndependent Non Exe. Director2026
Prapti Ishwar GiladaIndependent Non Exe. Director2026
Harshil Jiten VoraIndependent Non Exe. Director2026
Nishant A. ShahIndependent Non Exe. Director2026
Anandh SundarIndependent Non Exe. Director2026
Brijesh KumarCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Diagnostic services₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10300159159
Corporate Actions
TypeDateValueRemark
dividend2026-06-23₹7.0 (70.0%)Final
dividend2026-06-23₹7 (70%)Final
bonus2025-11-282:12:1 Bonus Issue of Equity Shares
dividend2025-10-24₹7 (70%)Interim
dividend2025-07-25₹21 (210%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026110080247
20268000025
202610080120
Insider / Designated-Person Trades

30 recent disclosure(s)

Nikhil BodhankarDisposal · 90
Nikhil BodhankarDisposal · 90
Nikhil BodhankarDisposal · 200
Nikhil BodhankarDisposal · 90
Nikhil BodhankarDisposal · 200
Sarovar ChandraAcquisition · 450
Substantial Acquisitions (SAST)

5 disclosure(s)

Market24/10/2025 · 53,32,860
Market24/10/2025 · 19,98,400
Creation Of Pledge30/09/2022 · —
Off Market02/09/2021 · 3,49,72,999
Off Market02/09/2021 · 3,49,72,999
Company Information
Incorporated2000
ChairmanRahul Franklin Guha
AuditorMSKA & Associates
Investor Email[email protected]; [email protected]
🌐 www.thyrocare.com ↗

📍 D-37/1 TTC Industrial Area, MIDC Turbhe, Navi Mumbai, Maharashtra, 400703

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Leela Palaces Hotel Ltd.Themis Medicare Ltd.Thermax Ltd.Thinking Hats Enter Sol LimitedThomas Cook (India) Ltd.Thomas Scott (India) Ltd.Tilaknagar Industries Ltd.Twamev Cons And Infra Ltd.Tiger Logistics (India) LimitedTechnocraft Ind Ltd.Tube Invest Of India Ltd.Tijaria Polypipes Ltd.All “T” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search